The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection

J Oncol Pract. 2019 Dec;15(12):639-640. doi: 10.1200/JOP.19.00664.

Authors

Yiannis Koullias^{1

2}, Sarah P Hammond^{1

2}

Affiliations

¹ Brigham and Women's Hospital, Boston, MA.
² Harvard Medical School, Boston, MA.

PMID: 31825757
DOI: 10.1200/JOP.19.00664

No abstract available

Publication types

Comment

MeSH terms

Antiviral Agents*
Hepacivirus
Hepatitis C*
Hepatitis C, Chronic*
Humans
Neoplasms*

Substances

Antiviral Agents